These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 1627786)
21. Class II MHC gene expression in microglia. Regulation by the cytokines IFN-gamma, TNF-alpha, and TGF-beta. Panek RB; Benveniste EN J Immunol; 1995 Mar; 154(6):2846-54. PubMed ID: 7876554 [TBL] [Abstract][Full Text] [Related]
23. Autoimmunity and bone. Schwarz EM; Looney RJ; Drissi MH; O'Keefe RJ; Boyce BF; Xing L; Ritchlin CT Ann N Y Acad Sci; 2006 Apr; 1068():275-83. PubMed ID: 16831928 [TBL] [Abstract][Full Text] [Related]
24. The effects of NO synthase inhibitors on murine collagen-induced arthritis do not support a role of NO in the protective effect of IFN-gamma. Vermeire K; Thielemans L; Matthys P; Billiau A J Leukoc Biol; 2000 Jul; 68(1):119-24. PubMed ID: 10914498 [TBL] [Abstract][Full Text] [Related]
25. Mutational analysis of TNF-alpha gene reveals a regulatory role for the 3'-untranslated region in the genetic predisposition to lupus-like autoimmune disease. Jacob CO; Lee SK; Strassmann G J Immunol; 1996 Apr; 156(8):3043-50. PubMed ID: 8609427 [TBL] [Abstract][Full Text] [Related]
26. The major histocompatibility complex and autoimmunity. Chaplin DD; Kemp ME Year Immunol; 1988; 3():179-98. PubMed ID: 3327310 [TBL] [Abstract][Full Text] [Related]
27. Tumour necrosis factor-alpha in murine autoimmune 'lupus' nephritis. Jacob CO; McDevitt HO Nature; 1988 Jan; 331(6154):356-8. PubMed ID: 2893286 [TBL] [Abstract][Full Text] [Related]
28. Inhibition of superantigen-induced proinflammatory cytokine production and inflammatory arthritis in MRL-lpr/lpr mice by a transcriptional inhibitor of TNF-alpha. Edwards CK; Zhou T; Zhang J; Baker TJ; De M; Long RE; Borcherding DR; Bowlin TL; Bluethmann H; Mountz JD J Immunol; 1996 Aug; 157(4):1758-72. PubMed ID: 8759766 [TBL] [Abstract][Full Text] [Related]
29. The cellular basis for immune interferon production in autoimmune MRL-Ipr/Ipr mice. Santoro TJ; Benjamin WR; Oppenheim JJ; Steinberg AD J Immunol; 1983 Jul; 131(1):265-8. PubMed ID: 6408174 [TBL] [Abstract][Full Text] [Related]
34. The possible role of tumor necrosis factor (TNF) and its natural inhibitors, the soluble-TNF receptors, in autoimmune diseases. Aderka D; Engelmann H; Wysenbeek AJ; Levo Y Isr J Med Sci; 1992 Feb; 28(2):126-30. PubMed ID: 1313788 [No Abstract] [Full Text] [Related]
36. The type I interferon system in the development of lupus. Rönnblom L; Alm GV; Eloranta ML Semin Immunol; 2011 Apr; 23(2):113-21. PubMed ID: 21292501 [TBL] [Abstract][Full Text] [Related]
38. Recent acquisitions on the genetic basis of autoimmune disease. Hill NJ; King C; Flodstrom-Tullberg M Front Biosci; 2008 May; 13():4838-51. PubMed ID: 18508549 [TBL] [Abstract][Full Text] [Related]
39. MHC class I polymorphism in lupus-prone MRL/Mp mice. Peng SL; Craft J Immunogenetics; 1996; 44(5):407-8. PubMed ID: 8781130 [No Abstract] [Full Text] [Related]